Patents by Inventor Daniel Gondol

Daniel Gondol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION FOR CONTROLLING PARASITES ON NON-HUMAN ORGANISMS
    Publication number: 20230090439
    Abstract: The present invention relates to a pharmaceutical composition comprising at least one pharmaceutically active ingredient, which is completely soluble in a solvent phase, characterized in that the pharmaceutically active ingredient is in particular from the group of fluorinated heteroarylamides, and that the solvent phase is configured as a solvent mixture and comprises at least one first solvent and a second solvent different from the first solvent, wherein the first solvent comprises a C1 to C15-alcohol, wherein the second solvent comprises an organic carbonate, and also wherein the first solvent is present in a proportion from 50% by weight to 95% by weight and wherein the second solvent is present in a proportion from 5% by weight to 50% by weight, based in each case on the sum total of the solvents in the solvent phase.
    Type: Application
    Filed: January 27, 2021
    Publication date: March 23, 2023
    Inventors: Anne FROEHLICH, Andreas TURBERG, Sandra MENSINGER, Daris GRIZIC, Daniel GONDOL, William BARTON
  • Use of efomycins
    Patent number: 6291515
    Abstract: The present invention relates to the use of known efomycins and elaiophylins for the treatment of autoimmune disorders, to new natural substances efomycins M and T, and processes for their preparation; in particular to their use as medicaments in psoriasis therapy.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: September 18, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Horst-Peter Antonicek, Erwin Bischoff, Daniel Gondol, Oliver Gutbrod, Thomas Krahn, Maria-Luisa Rodriguez, Helmuth Schütz
  • Use of efomycins
    Patent number: 6225337
    Abstract: The present invention relates to the use of known efomycins and elaiophylins for the treatment of autoimmune disorders, to new natural substances efomycins M and T, and processes for their preparation; in particular to their use as medicaments in psoriasis therapy.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: May 1, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Horst-Peter Antonicek, Erwin Bischoff, Daniel Gondol, Oliver Gutbrod, Thomas Krahn, Maria-Luisa Rodriguez, Helmuth Schütz